Baricitinib (LY3009104) 2 mg

DRUG2 trials

Sponsors

Aaron R. Mangold, Emory University

Conditions

Cutaneous Lichen PlanusHIVHIV Infection

Phase 2

Baricitinib (LY3009104) in the Treatment of Cutaneous Lichen Planus

CompletedNCT05188521

Aaron R. MangoldCutaneous Lichen Planus

Start: 2022-01-11End: 2023-05-17Updated: 2024-06-11

Baricitinib Curative Repression of HIV-1

Not yet recruitingNCT07209267

Emory UniversityHIV, HIV Infection

Start: 2026-03-01End: 2028-01-01Target: 20Updated: 2026-02-23

Related Papers

Repurposing the composite assessment of index lesion severity scoring system in cutaneous lichen planus.

2025-02-14

Rapid response of lichen planus to baricitinib associated with suppression of cytotoxic CXCL13+CD8+ T cells

Journal of Clinical Investigation2024-11-148 citations